我要投票 达因盖笛欣在补钙行业中的票数:299
· 外 推 电 报 ·
2025-05-09 20:33:21 星期五

【达因盖笛欣是哪个国家的品牌?】

达因盖笛欣是什么牌子?「达因盖笛欣」是 山东达因海洋生物制药股份有限公司 旗下著名品牌。该品牌发源于山东,由创始人张璨在1994-10-27期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力达因盖笛欣品牌出海!将品牌入驻外推网,定制达因盖笛欣品牌推广信息,可以显著提高达因盖笛欣产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

山东达因海洋生物制药股份有限公司成立于1994年10月,是一家高科技制药企业,注册地在山东省荣成市。公司名称原为威海达因海洋生物制药有限公司,2000年10月,因公司发展的需要,整体改制为股份公司,同时更名为山东达因海洋生物制药股份有限公司,目前公司注册资金6000万元,公司总资产达20000多万元。下设全资子公司北京达因康健医药有限责任公司。

公司主要股东为山大华特科技股份有限公司、荣成市公有资产经营有限公司和中国医学科学院医药生物技术研究所等,其中山大华特科技股份有限公司是山东大学控股的山东省高校唯一上市公司。公司的主营业务为生产销售中西药制剂及原料药、海洋生物药品,产品主要以儿童保健和治疗领域为主,产品是:伊可新(维生素AD胶囊型)、盖笛欣(复方碳酸钙泡腾颗粒剂)、伊甘欣(甘草锌颗粒剂),同时涉及内分泌、心血管、消化系统及抗感染等领域,剂型有软胶囊、硬胶囊、片剂、颗粒剂和原料药。公司管理总部设在北京,生产基地位于山东荣成,并在全国设有20多个销售分支机构。

公司现有生产基地(荣成)厂区占地面积53亩,建筑面积约2万平方米,拥有软胶囊、固体制剂等多条现代化生产线及原料药车间,所有生产线全部通过了国家GMP认证,目前年可生产软胶囊6亿粒,颗粒剂1亿袋。另外,公司已经开工建设的新厂区占地近200亩,预计2009年建成投产后将具备软胶囊12亿粒、颗粒剂10亿袋、口服液5亿支的生产能力。

公司以“使千千万万中国儿童健康强壮”为己任,致力于“成为儿童保健和治疗领域的领军企业”的宏伟战略目标,自成立以来一直以管理规范、业绩优良、成长性好在业内赢得广泛好评。1997年被山东省科委评为高新技术企业,2003年被威海市评为百佳诚信企业,2004年公司产品“伊可新”商标被评为山东省著名商标,并被评为山东省名牌产品,2008年3月“伊可新”商标又被国家工商总局评为中国“驰名保护”。公司销售收入连年增长,年平均增长率均保持在50%以上。根据国家发展和改革委员会的《中国医药统计年报》2005年公司的销售收入、利润总额进入全国化学制药工业前200强的行列。主要产品伊可新已连续九年保持同类产品市场占有率第一。

公司现有员工五百余人,是一个具有优秀的专业化素质以及强烈“责任心、进取心和事业心”和高度执行力的朝气蓬勃的团队。公司秉承“认真做事,诚信做人”的价值观,本着“勤奋、务实、高效、创新”的工作准则,努力为员工创造良好的工作氛围,搭建公司百年发展平台,保证公司稳健经营和持续发展,服务社会,贡献大众。

英文翻译:Shandong dyne marine biopharmaceutical Co., Ltd. was founded in October 1994. It is a high-tech pharmaceutical enterprise, registered in Rongcheng City, Shandong Province. The name of the company was originally Weihai dyne marine bio Pharmaceutical Co., Ltd. in October 2000, due to the needs of the company's development, the company was restructured as a joint-stock company as a whole, and was renamed as Shandong dyne marine bio Pharmaceutical Co., Ltd. at present, the registered capital of the company is 60 million yuan, and the total assets of the company are more than 200 million yuan. It has a wholly-owned subsidiary Beijing dyne Health Medicine Co., Ltd. The main shareholders of the company are Shanda Huate Technology Co., Ltd., Rongcheng City Public Assets Management Co., Ltd. and Institute of pharmaceutical biotechnology, Chinese Academy of Medical Sciences, etc., among which Shanda Huate Technology Co., Ltd. is the only listed company in Shandong Universities controlled by Shandong University. The main business of the company is to produce and sell Chinese and Western medicine preparations, APIs and marine biological drugs. The products are mainly in the field of children's health care and treatment. The products are: ikosin (vitamin AD capsule type), gedixin (compound calcium carbonate effervescent granules), iganxin (glycyrrhizin zinc granules). Meanwhile, they are involved in the fields of endocrine, cardiovascular, digestive system and anti infection Type A includes soft capsule, hard capsule, tablet, granule and API. The company's management headquarters is located in Beijing, the production base is located in Rongcheng, Shandong Province, and has more than 20 sales branches across the country. The company's existing production base (Rongcheng) covers an area of 53 mu, with a building area of about 20000 square meters. It has a number of modern production lines and API workshops, including soft capsules and solid preparations. All production lines have passed the national GMP certification. At present, it can produce 600 million soft capsules and 100 million bags of granules annually. In addition, the company has started the construction of a new plant area of nearly 200 mu, which is expected to have a production capacity of 1.2 billion soft capsules, 1 billion bags of granules and 500 million pieces of oral liquid when it is completed and put into operation in 2009. The company takes "making tens of millions of Chinese children healthy and strong" as its own responsibility, and is committed to the grand strategic goal of "becoming a leading enterprise in the field of children's health care and treatment". Since its establishment, it has been widely praised in the industry for its standardized management, excellent performance and good growth. In 1997, it was rated as a high-tech enterprise by Shandong Provincial Science and Technology Commission; in 2003, it was rated as one of the top 100 integrity enterprises by Weihai City; in 2004, the company's product "ikxin" trademark was rated as a famous trademark in Shandong Province, and it was rated as a famous brand product in Shandong Province; in March 2008, the "ikxin" trademark was rated as China's "well-known protection" by the State Administration of industry and commerce. The company's sales revenue has been increasing year by year, with an average annual growth rate of more than 50%. According to the annual report of China Pharmaceutical statistics issued by the national development and Reform Commission, the company's total sales revenue and profit in 2005 ranked among the top 200 in the national chemical pharmaceutical industry. The market share of its main products, icoxin, has been the first for nine consecutive years. The company has more than 500 employees. It is a vigorous team with excellent professional quality, strong sense of responsibility, enterprise and high execution. The company adheres to the value of "doing things conscientiously, being a man with integrity", and the working principle of "diligence, pragmatism, efficiency and innovation", strives to create a good working atmosphere for employees, build a century long development platform of the company, ensure the stable operation and sustainable development of the company, serve the society and contribute to the public.

本文链接: https://www.waitui.com/brand/f98a48d31.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

证监会、财政部就《证券结算风险基金管理办法(修订草案征求意见稿)》公开征求意见

36氪获悉,证监会、财政部就《证券结算风险基金管理办法(修订草案征求意见稿)》公开征求意见。《办法》拟规定,结算参与人权益类和固定收益类品种现券交易计收比例下调至原有标准的十分之三,质押式回购业务计收比例维持不变。明确风险基金净资产总额不少于30亿元,达到或超过上述规模后,证券登记结算机构不再提取。

34分钟前

国内首个具身智能康复示范基地落地上海

5月9日,上海机器人企业傅利叶与上海国际医学中心举行了“具身智能康复港”揭牌仪式。双方将围绕具身智能机器人在康复医疗场景的应用标准建设、康复方案共创、科研攻关等展开全面合作,携手打造国内首个具身智能康复示范基地。(第一财经)

34分钟前

中国贸促会会长任鸿斌会见美国埃克森美孚公司全球高级副总裁魏捷凯

36氪获悉,5月9日,中国贸促会会长任鸿斌在京会见美国埃克森美孚公司全球高级副总裁魏捷凯一行,双方围绕优化外资企业在华营商环境、共促绿色低碳发展、加强产业链供应链合作等议题展开深入交流。

34分钟前

上海技术交易所微短剧专板启动

上海技术交易所微短剧专板正式启动。其中,作为上海技术交易所国际业务平台的上技国际,将在临港新片区建设可信数据空间,联盟短剧制作方、版权方和平台发行方,培育产业新业态,探索短剧数据上链、跨境结算与分账规则。(财联社)

34分钟前

美联储官员巴尔:关税可能导致通胀和失业上升

美联储理事Michael Barr表示,特朗普政府的贸易政策可能会造成持续性的通胀压力及失业增加,使美联储陷入困境。不过他指出,在关税对经济的影响进一步明朗化之前,利率仍处于有利位置。Barr附和了美联储主席鲍威尔的表态,后者本周早些时候称美国经济依然稳固,让官员们可以耐心等待更多有关关税及其影响的信息。(新浪财经)

34分钟前

本页详细列出关于达因盖笛欣的品牌信息,含品牌所属公司介绍,达因盖笛欣所处行业的品牌地位及优势。
咨询